Cardiology Unit, "Card. G. Panico" Hospital, Tricase, Italy.
Cardiology Unit, "Card. G. Panico" Hospital, Tricase, Italy; Cardiology Unit, Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.
Am J Cardiol. 2023 Dec 15;209:76-84. doi: 10.1016/j.amjcard.2023.09.093. Epub 2023 Oct 19.
Ablate and pace (A&P) with conduction system pacing (CSP) improves outcomes in patients with symptomatic permanent atrial fibrillation (AF). Data on spontaneous sinus rhythm restoration (SSRR) in this setting are lacking. This study aimed to assess the incidence and the predictors of SSRR in a population of patients with permanent AF who underwent A&P with CSP. Prospective, observational study, enrolling consecutive patients with symptomatic permanent AF (of documented duration >6 months) and uncontrolled, drug-refractory high ventricular rate, who underwent A&P with CSP. The incidence and predictors of SSRR were prospectively assessed. A total of 107 patients (79.0 ± 9.1 years, 33.6% male, 74.8% with New York Heart Association class ≥III, 56.1% with ejection fraction <40%) were enrolled: 40 received His' bundle pacing, 67 left bundle branch area pacing. During a median follow-up of 12 months SSRR was observed in 14 patients (13.1%), occurring a median of 3 months after A&P (interquartile range 1 to 6; range 0 to 17). Multivariable analysis identified a duration of permanent AF <12 months (hazard ratio 7.7, p = 0.040) and a left atrial volume index <49 ml/m (hazard ratio 14.8, p = 0.008) as independent predictors of SSRR. In patients with coexistence of both predictors the incidence of SSRR was of 41.4%. In a population of patients with symptomatic, permanent AF, treated with A&P with CSP, SSRR was observed in 13% of patients during follow-up. A duration of permanent AF <12 months and a left atrial volume index <49 ml/m were independent predictors of this phenomenon.
消融和起搏(A&P)联合心脏传导系统起搏(CSP)可改善有症状的永久性心房颤动(AF)患者的结局。目前缺乏关于这种情况下自发性窦性节律恢复(SSRR)的数据。本研究旨在评估接受 A&P+CSP 治疗的永久性 AF 患者人群中 SSRR 的发生率和预测因素。
前瞻性、观察性研究,纳入有症状的永久性 AF(记录的持续时间>6 个月)且伴有无法控制的、药物难治性的心室率高的患者,这些患者接受 A&P+CSP。前瞻性评估了 SSRR 的发生率和预测因素。共纳入 107 例患者(79.0±9.1 岁,33.6%为男性,74.8%纽约心脏协会(NYHA)心功能分级≥III 级,56.1%射血分数<40%):40 例接受希氏束起搏,67 例接受左束支区域起搏。在中位随访 12 个月期间,14 例患者(13.1%)观察到 SSRR,A&P 后中位时间 3 个月(四分位距 1 至 6;范围 0 至 17)。多变量分析发现,永久性 AF 持续时间<12 个月(危险比 7.7,p=0.040)和左心房容积指数<49ml/m(危险比 14.8,p=0.008)是 SSRR 的独立预测因素。在同时存在这两个预测因素的患者中,SSR 的发生率为 41.4%。在接受 A&P+CSP 治疗的有症状的永久性 AF 患者人群中,随访期间有 13%的患者观察到 SSRR。永久性 AF 持续时间<12 个月和左心房容积指数<49ml/m 是这一现象的独立预测因素。